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Dementia is a disease of progressive cognitive decline 
with relatively intact consciousness. International 
classification of diseases ICD 10 describes it “as a 
syndrome due to disease of the brain, usually of 
chronic or progressive nature, in which there is 
evidence of a decline in both memory and thinking 
which is sufficient to impair personal activities of daily 
living, without clouding of consciousness and is 
commonly accompanied or preceded by deterioration 
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in emotional control, social behaviour or motivation.[1] 
If not properly managed, these demented subjects 
may become helpless, incapable of remembering the 
names of close relatives, they may wander into 
dangerous situations, oblivious of their surroundings. 
Alzheimer’s Dementia is a progressive relentless loss 
of mental function characterized by degeneration of 
brain tissue including loss of nerve cells and 
development of senile plaques and neurofibrillary 
tangles. It’s prevalence in those over 60 years of age 
ranges between 5-20% in the western nations, 
Dementia (and Alzheimer’s Disease) prevalence rate 
in India 4.86 % (1.91 %) in age > 55 years and 6.44 % 
(3.56%) in age >65 years.[2] 
The drugs promoting Medha (intellect), Smriti 
(memory) are termed as Medhya drugs. Ayurveda 
System of Medicine has mentioned several medicinal 
plants under the category 'Medhya'. By virtue of 
improving cognitive abilities major influence several 
medicinal plants mentioned as 'Rasayana Drugs' in 
Ayurveda are primarily claimed as 'Medhya'. Further 
there is a special class of some Rasāyana drugs called 
A B S T R A C T  
Dementia is defined as an acquired deterioration in cognitive abilities that impairs the performance of 
activities of daily living. In Ayurveda literatures this disease is explained under the concept of Jara 
Vyadhi. In elderly people there will be loss of cognitive abilities viz. Grahana, Dharana and Smarana 
because there is gradual diminution in the qualities of Dhatu and dominance of Vata. An individual can 
lead a normal happy life if one has a sound intellectual capacity with a good memory. Any 
impairments to his memory will has an effect on the quality of his living standards, thus this condition 
is chosen for the present study. Present study is a single group open clinical trial with pre and post-
test design on 30 subjects. Subjects were administered with Ashtanga Ghrita for 60 days. The results 
were obtained on parameter viz. Impaired memory, Visuospatial disorientation, Apraxia, Impaired 
visuoconstructional drawing, Impaired judgement, Impaired language the result obtained statistically 
non-significant in the management of Dementia. However, it was observed the symptoms such as 
anger and irritability were reduced. 
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'Medhya Rasayana' which is supposed to be having 
specific influence on higher brain functions. Keeping 
in view the above concepts, signify the role of Ghrita 
in improving mental functions Bruhmana Sneha 
administration of Ashtanga Ghrita has been selected 
in this study. 
OBJECTIVE OF THE STUDY 
To evaluate the efficacy of Ashtanga Ghrita in 
Dementia. 
MATERIALS AND METHODS 
Source of Data 
Subjects were selected from the OPD and IPD of 
Government Ayurveda Medical College and Hospital, 
Mysuru, Government Hi - Tech Panchakarma Hospital, 
Mysuru, Old Age Home in Mysuru, special camps and 
other referral sources.  
Inclusion Criteria 
Subjects of all gender between the age group of 60-85 
years with Senile Dementia and diagnosed cases of 
Alzheimer’s Disease were selected. 
Exclusion Criteria 
Secondary Dementia caused due to Parkinson’s 
disease, vascular causes, head injury, alcohol abuse, 
hydrocephalus, HIV and syphilis were excluded. 
Subjects suffering from uncontrolled diabetes mellitus 
(RBS>250mg/dL), hypertension (>170/100mmHg), 
ischemic heart disease and other systemic disorders 
which interferes with the course of intervention were 
excluded. 
Diagnostic Criteria 
Diagnostic and Statistical Manual-5 (DSM 5) criteria 
was used for diagnosis, that is - one or more acquired 
significant impairments (independence lost) in 
cognitive domains such as: 
1. Memory (amnesia) 
2. Language (aphasia) 
3. Execution of purposeful movement (apraxia) 
4. Recognition / familiarity (agnosia) 
5. Visuopatial function (topographical 
disorientation) 
6. Self-control / management (executive functions 
impairment) 
7. Other examples: 
a) Mathematics (dyscalculia) 
b) Emotional expression /comprehension 
(dysprosody) 
c) Writing (agraphia) 
Assessment 
Assessment was done based on - The Rowland 
Universal Dementia Assessment Scale: A Multicultural 
Cognitive Assessment Scale.[3] 
Statistical Methods 
The results were analysed statistically by using below 
statistical methods. 
▪ Descriptive statistics 
▪ Chi-square test 
▪ Paired sample ‘T’ test 
▪ Using SPSS for windows 
Intervention 
Bruhmana Sneha Prayoga of Ashtanga Ghrita for 60 
days. 
Dose - 12 gm as a single dose per day. 
Anupana - Hot water 
Time of administration - (5.30 am- 9am) before food 
The assessment was done based on following 3 
schedules; 
Pre-test assessment - Before the commencement of 
intervention (day zero). 
Mid test assessment - In the middle of intervention 
(30th day). 
Post-test assessment - After the completion of 
intervention (60th day).  
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OBSERVATION AND RESULTS 
The data was collected from the subjects based on 
diagnostic criteria. The results were analysed 
statistically using Pearson Chi-Square test. 
Memory impairment 
Out of 30 subjects, before intervention 2 subjects 
(6.7%) had score 0, 4 subjects (13.3%) had score 2, 11 
subjects (36.7%) had score 4, and 13 subjects (43.3%) 
had score 6 on Memory impairment.  
On 30th day of intervention, out of 30 subjects, 2 
subjects (6.7%) had score 0, 2 subjects (6.7%) had 
score 2, 15 subjects (50.0%) had score 4 and 11 
subjects (36.7%) had score 6 on   Memory 
impairment.  
After the completion of intervention on 60th day, 2 
subjects (6.7%) had score 0, 2 subjects (6.7%) had 
score 2, 15 subjects (50.0%) had score 4 and 11 
subjects (36.7%) had score 6 on Memory impairment. 
The result obtained regarding the parameter on 
Memory impairment showed statistically insignificant 
result with P value p- 0.919. 
Visuospatial disorientation 
Out of 30 subjects, before intervention 30 subjects 
(100%) had score 5 on Visuospatial disorientation.  
On 30th day of intervention, 30 subjects (100%) had 
score 5 on Visuospatial disorientation.  
After the completion of intervention on 60th day, 30 
subjects (100%) had score 5 on Visuospatial 
disorientation. 
Apraxia 
Out of 30 subjects, before intervention 1 subject 
(3.3%) had score 0, 29 subjects (96.6%) had score 2 on 
Apraxia.  
On 30th day of intervention, out of 30 subjects, 2 
subjects (6.7%) had score 1, 28 subjects (93.3%) had 
score 2 on Apraxia.  
After the completion of intervention on 60th day, 2 
subjects (6.7%) had score 1, 28 subjects (93.3%) had 
score 2 on Apraxia. 
The result obtained regarding the parameter on 
Apraxia showed statistically insignificant result with P 
value p- 0.673. 
Impaired visuoconstructional drawing 
Out of 30 subjects, before intervention 2 subjects 
(6.7%) had score 1, 12 subjects (40%) had score 2, 16 
subjects (53.3%) had score 3 on Impaired 
visuoconstructional drawing.  
On 30th day of intervention, out of 30 subjects, 3 
subjects (10%) had score 1, 11 subjects (36.7%) had 
score 2, 16 subjects (53.3%) had score 3 on Impaired 
visuoconstructional drawing.  
After the completion of intervention on 60th day, 3 
subjects (10%) had score 1, 11 subjects (36.7%) had 
score 2, 16 subjects (53.3%) had score 3 on Impaired 
visuoconstructional drawing. 
The result obtained regarding the parameter on 
Impaired visuoconstructional drawing showed 
statistically insignificant result with P value p- 0.989. 
Impaired judgement 
Out of 30 subjects, before intervention 1 subject 
(3.3%) had score 0, 1 subject (3.3%) had score 2, 1 
subject (3.3%) had score 3, and 27 subjects (3.3%) had 
score 4 on Impaired judgement.  
On 30th day of intervention, out of 30 subjects, 1 
subject (3.3%) had score 1, 5 subjects (16.7%) had 
score 3, 24 subjects (80.0%) had score 4 on Impaired 
judgement. 
After the completion of intervention on 60th day, 1 
subject (3.3%) had score 1, 1 subject (3.3%) had score 
2, 4 subjects (13.3%) had score 3 and 24 subjects 
(80%) had score 4 on Impaired judgement. 
The result obtained regarding the parameter on 
Impaired judgement showed statistically insignificant 
result with P value p- 0.554. 
Impaired language 
Out of 30 subjects, before intervention 1 subject 
(3.3%) had score 3, 2 subjects (6.7%) had score 4, 4 
subjects (13.3%) had score 5, 8 subjects (26.7%) had 
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score 6, 2 subjects (6.7%) had score 7 and 13 subjects 
(43.3%) had score 8 on Impaired language.  
On 30th day of intervention, out of 30 subjects, 6 
subjects (20%) had score 4, 2 subjects (6.7%) had 
score 5, 8 subjects (26.7%) had score 6, 3 subjects 
(10%) had score 7 and 11 subjects (36.7%) had score 8 
on Impaired language.  
After the completion of intervention on 60th day, 4 
subjects (13.3%) had score 4, 5 subjects (16.7%) had 
score 5, 6 subjects (20%) had score 6, 2 subjects 
(6.7%) had score 7 and 13 subjects (43.3%) had score 
8 on Impaired language. 
The result obtained regarding the parameter on 
Impaired language showed statistically insignificant 
result with P value p- 0.804. 
DISCUSSION 
According to Charaka Samhitha, Prajna has three 
components which are Dhee, Dhriti and Smriti.[4] In 
Dementia there may be impairment of all these 
components with intact consciousness. The prime 
component affected is Dhee which can be considered 
as cognitive decline. As Dhee and Smriti are 
interlinked with each other along with cognitive 
decline, memory impairment an important feature of 
Dementia.  
According to Charaka Samhitha disease is named 
based on Prakruthi, site of manifestation, causative 
factors, and signs and symptoms. Discussed in the 
context of Vataja Nanatmaja Vikara Vataja Bhrama is 
a condition which has close resemblance with 
Dementia. Impairment of Smriti is one of its important 
features. However specific term for Dementia is not 
mentioned in any Ayurveda classical textbooks. 
It is mentioned in Charaka Samhitha that during old 
age quantity as well as quality of Dhatu is decreased. 
Role of Agni in Ageing - Dhatu are regularly nourished 
by dietary substances and Agni is responsible for the 
conversion of dietary substances into formation of 
Dhatu. 
Dominance of Vata Dosha is responsible for 
Vishamagni which affects the digestion and causes 
under nourishment of the Dhatu.  
It may have an impact on low status of Dhatvagni and 
nourishment for Uttarottara Dhatu. 
Dementia occurs mainly in Jara, impairment of Prajna 
occurs due to the effect of Dementia. Since the action 
of Rasayana is in the whole body, changes occur at 
both, physical and psychological level. 
According to various research works nootropic drugs 
are a heterogeneous group of drugs developed in 
Dementia and other cerebral disorders. They decrease 
levels of arousals and stress in the central nervous 
system. It is suggested to improve attention, learning, 
memory, and vigilance. Promote healthy brain 
functioning by repairing damage, promoting nerve 
growth, and maintaining neuronal health. Many of 
these supplements are taken for their antioxidant 
properties and are thought to help maintain optimal 
cognition and prevent cognitive decline. 
Medhya Rasayana is type of Rasayana which is said to 
improve the cognitive functions. The benefits of the 
Medhya Rasayana are similar to nootropics in few 
aspects. 
Ashtanga Ghrita is a well-balanced preparation 
including the drugs which have Medhya, Rasayana, 
Smritikara and Ayushya properties.[5] The Ingredients 
of Ashtanga Ghrita includes following drugs as 
follows: 
Bakuchi which possesses Rasayana action, dietary 
total prenylflavonoids from the fruits of Psoralea 
corylifolia prevents age related cognitive deficits and 
down regulates Alzheimer’s markers.[6] 
Vidhara also Vrishya, has Rasayana properties and it 
contains scopoletin: antiamyloidogenic, 
anticholinesterase, and neuroprotective potential of a 
natural compound.[7] 
Shankapushpi and Mandookaparni has Medhya 
action, both are Tikta Rasa in nature. 
Shatavari has Rasayana properties and its ethanolic 
extracts from roots possesses an outstanding source 
for natural nootropic.[8] 
Brahmi also having Medhya, Rasayana action, it 
contains antioxidant properties to reduce oxidative 
stress in the ageing brain.[9] 
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Vacha has Medhya action, studies showed that Acorus 
calamus rhizome extract effect on the 
neuromodulatory system.[10] 
Guduchi is one among the Medhya Rasayana and 
research studies showed that it has possesses free 
radical scavenging and anti-proliferative activities.[11] 
Cow’s milk has Madhura Rasa, Madhura Vipaka, 
Vatahara properties. It nourishes all Dhatu right down 
to the Ojas. 
Ghrita is said to be Vatahara also Smriti Kara, 
Medhakara, Ayushya and it increases the Agni. It acts 
as a Rasayana which gives strength to the body. It 
receives the properties of Samskara (processing with 
drugs). Ghee has been considered immensely superior 
to other fats mainly because of the presence of short 
chain fatty acids and carrier of four fat soluble 
vitamins A, D, E, K. Hence by virtue of its lipid soluble 
property it can cross Blood Brain Barrier thus proving 
as an effective drug for CNS.[12] 
Majority of the ingredients in Ashtanga Ghrita are 
having Madhura Vipaka, Medhya, Rasayana, 
Vatahara properties.  It will do the Dhatuposhana 
helping the management of Dementia. 
Thus, Ashtanga Ghrita is a neurotropic drug both as a 
prophylactic and curative medication. 
The results obtained on parameter Impaired Memory 
impairment, Visuospatial disorientation, Apraxia, 
Impaired visuoconstructional drawing, Impaired 
judgement, Impaired language was statistically non-
significant in the management of Dementia. 
Reason for statistically nonsignificant results 
The nonsignificant result obtained may be due to 
short duration of the intervention. As Dementia is one 
of the chronic progressive disorders it needs months 
of regular efforts to delay the progress of the disease. 
Sample size was small to draw the conclusion and 
generalise it. 
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